Jan. 22, 2025 /PRNewswire/ -- ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology ...
Tanvex BioPharma, Inc. ("Tanvex"), a contract development and manufacturing organization (CDMO) for biologics and a biosimilars products company, is pleased to announce the successful completion ...
Key opinion leaders interviewed by GlobalData expressed optimism about biologics in COPD. Image: Jo Panuwat D via Shutterstock. The chronic obstructive pulmonary disease (COPD) market continues its ...